Arrowhead Pharmaceuticals (ARWR) Exchange Rate Effect (2021 - 2026)
Arrowhead Pharmaceuticals' (ARWR) quarterly Exchange Rate Effect came in at $997000.0 in Q1 2026, up 348.01% YoY from $222539.7 in Q1 2025, and up 840.57% on a QoQ basis from $106000.0 in Q4 2025.
Arrowhead Pharmaceuticals (ARWR) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals (ARWR) has 6 years of Exchange Rate Effect data on file, last reported at $997000.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 348.01% year-over-year to $997000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 67.83% YoY) and the FY2025 annual result came in at -$401000.0, down 109.55% from the prior year.
- Exchange Rate Effect rose to $997000.0 in Q1 2026, from $106000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $4.3 million in Q3 2024 to a low of -$402000.0 in Q1 2025.
- A 5-year average of $279352.9 and a median of $1000.0 in 2022 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 5000.0% in 2023, down 7500.0% in 2023.
- Tracing ARWR's Exchange Rate Effect over 5 years: stood at -$122000.0 in 2022, then soared by 147.54% to $58000.0 in 2023, then slumped by 217.24% to -$68000.0 in 2024, then jumped by 255.88% to $106000.0 in 2025, then soared by 840.57% to $997000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $997000.0 (Q1 2026), $106000.0 (Q4 2025), and -$24000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Arrowhead Pharmaceuticals | 12.23 Bn | 10.63 Bn | - | 477,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 477,000.00 |
| Jun 30, 2026 | 477,000.00 |
| Mar 31, 2026 | 997,000.00 |
| Mar 31, 2026 | 997,000.00 |
| Dec 31, 2025 | 106,000.00 |
| Dec 31, 2025 | 106,000.00 |
| Sep 30, 2025 | -24,000.00 |
| Sep 30, 2025 | -24,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | -402,000.00 |
| Mar 31, 2025 | -402,000.00 |
| Dec 31, 2024 | -68,000.00 |
| Dec 31, 2024 | -68,000.00 |
| Sep 30, 2024 | 4.34 Mn |
| Sep 30, 2024 | 4.34 Mn |
| Jun 30, 2024 | -223,000.00 |
| Jun 30, 2024 | -223,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Mar 31, 2024 | 26,000.00 |